Impaired growth at birth and bronchopulmonary dysplasia classification: beyond small for gestational age

Michael F Nyp1, Jane B Taylor1, Michael Norberg1

  • 1Department of Pediatrics, Center for Infant Pulmonary Disorders, The Children's Mercy Hospital, Kansas City, Missouri.

Insights

Infants born before 26 weeks gestational age experience significant growth issues and are at higher risk for bronchopulmonary dysplasia (BPD). Lower birth weight for gestational age, beyond standard small-for-gestational age, is linked to moderate/severe BPD.

Area of Science:

  • Neonatalogy
  • Pediatric Pulmonology
  • Growth and Development

Background:

  • Bronchopulmonary dysplasia (BPD) is a significant complication in preterm infants.
  • Intrauterine and postnatal growth are critical factors influencing preterm infant outcomes.
  • Understanding growth patterns in relation to BPD severity is essential for improving care.

Purpose of the Study:

  • To investigate the correlation between intrauterine and postnatal growth parameters and the classification of bronchopulmonary dysplasia (BPD) at 36 weeks postmenstrual age (PMA).
  • To identify growth-related risk factors for BPD in extremely preterm infants.

Main Methods:

  • Retrospective cohort study of infants born before 29 weeks gestational age (GA) between 2008 and 2010.
  • BPD classification based on physiological definition at 36 weeks PMA.
  • Comparison of growth parameters (birth weight, length, head circumference) at birth and 36 weeks PMA across different GA subgroups.

Main Results:

  • A cohort of 140 infants was analyzed, with a median GA of 27 weeks.
  • BPD prevalence: 20% no BPD, 27% mild, 31% moderate, 22% severe.
  • Infants born <26 weeks GA showed impaired linear and head circumference growth postnatally. All infants <26 weeks GA below the 25th percentile for weight developed moderate/severe BPD.

Conclusions:

  • Extremely preterm infants (<26 weeks GA) exhibit smaller birth size and significant postnatal growth deficits.
  • Lower birth weight for GA, even beyond the typical small-for-gestational age (SGA) definition, is associated with an increased risk of developing moderate to severe BPD.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
35
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
31
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
19.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K